Premium
Rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome
Author(s) -
Rao Indu R,
Pinnamaneni Siva Tez,
Ranjana Minz,
Ritambhra Nada,
Vivek Kumar,
Manish Rathi,
Kohli Harbir S,
Jha Vivekanand V,
Gupta Krishan,
Raja Ramachandran
Publication year - 2017
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.12924
Subject(s) - medicine , nephrology , nephrotic syndrome , rituximab , post graduate , family medicine , medical education , lymphoma